Cardiopulmonary

As part of our ultimate mission to lead where medicine is going, we aspire to deliver transformational, accessible therapies that alter the course of cardiopulmonary diseases, providing patients with the chance for longer, healthier lives.


© Janssen-Cilag NV/B.V., a Johnson&Johnson company – CP-490866 – Approval date: 11-2024, vu/er Luc Van Oevelen, Antwerpseweg 15-17, 2340 Beerse